International journal of microbiology · 2025
Burkholderia pseudomallei in Colombia: Laboratory Approaches to Enhance Diagnostic Accuracy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Morales-Lopez Soraya, Villero Wolf Yeneiris, Lechuga Deyner, Caicedo Luis, Acosta Triana Yiceth, Gomez Liliana, Ramirez Luis Rodrigo, Narvaez Leandro, Pinzon Heidy, Esquea Kelin, Barros Rafael, Martinez Ramos Pedro, Marin Adriana, Parra Claudia Marcela
Аннотация
BACKGROUND: Melioidosis is a challenging disease to diagnose, and diagnostic complications can delay treatment, adversely impacting patient outcomes.
METHODS: Over a period of 1 year, 68 isolates, initially identified as Burkholderia spp. or oxidase-positive nonfermenting Gram-negative bacilli (excluding Pseudomonas aeruginosa), were collected from laboratories in three Colombian cities. Four commercial identification systems were employed. After recovery on blood agar, all strains were cultured on Ashdown's and CHROMID Colistin R media. Comparative identification using automated systems was performed, and definitive identification was achieved through multiplex PCR.
RESULT: PCR identified three Burkholderia pseudomallei isolates and 59 Burkholderia cepacia complex isolates. The Microscan and Vitek 2 Compact systems successfully identified the B. pseudomallei isolates, whereas the Phoenix and MALDI-TOF Bruker systems did not. Ashdown's CHROM colistin media supported the growth of B. pseudomallei and various other genera and species. Species-level misidentifications were frequent.
CONCLUSION: Due to limitations of commercial identification systems and the morphological similarities between species, the use of molecular tools or a combination of confirmatory tests is crucial for accurately diagnosing B. pseudomallei in Colombia.
METHODS: Over a period of 1 year, 68 isolates, initially identified as Burkholderia spp. or oxidase-positive nonfermenting Gram-negative bacilli (excluding Pseudomonas aeruginosa), were collected from laboratories in three Colombian cities. Four commercial identification systems were employed. After recovery on blood agar, all strains were cultured on Ashdown's and CHROMID Colistin R media. Comparative identification using automated systems was performed, and definitive identification was achieved through multiplex PCR.
RESULT: PCR identified three Burkholderia pseudomallei isolates and 59 Burkholderia cepacia complex isolates. The Microscan and Vitek 2 Compact systems successfully identified the B. pseudomallei isolates, whereas the Phoenix and MALDI-TOF Bruker systems did not. Ashdown's CHROM colistin media supported the growth of B. pseudomallei and various other genera and species. Species-level misidentifications were frequent.
CONCLUSION: Due to limitations of commercial identification systems and the morphological similarities between species, the use of molecular tools or a combination of confirmatory tests is crucial for accurately diagnosing B. pseudomallei in Colombia.